At such a low dose, symptoms like mild body aches, low energy, sleep changes, or fatigue can sometimes occur during the final phase of clonazepam tapering and may represent mild withdrawal/adjustment symptoms, though other medical causes should also be considered if symptoms persist or worsen. Since you have an important event coming up and are otherwise stable, it may be reasonable to avoid making abrupt changes right now and discuss with your treating psychiatrist whether to continue the same slow taper until the event is over rather than stopping suddenly. Any further reduction is usually best done gradually and individually supervised.

Hi, yes continue. If you have any doubts regarding the same consult online for treatment

"Hi there, I understand that seeking help can feel overwhelming, but you’ve already taken the first brave step. I can guide you with a clear treatment plan tailored just for you, so you can feel better and regain control over your life. You can reach me directly on WhatsApp for quick support on seven zero eight two zero two two zero six two."

The symptoms described — low energy, sleepiness, mild body aches, and fatigue during the last phase of tapering — can occur during benzodiazepine tapering and may represent mild withdrawal or nervous system readjustment. Since there is no marked anxiety, panic, tremor, severe insomnia, agitation, or autonomic symptoms mentioned, this does not sound like severe withdrawal. At a dose of clonazepam 0.125 mg every third day, the body is already at a very low exposure level. However, the “every third day” pattern can sometimes produce small fluctuations in blood levels, which may itself cause intermittent symptoms in sensitive individuals. Because an important work event is scheduled from 6th–12th May, the safest approach is usually not to make further reductions or abrupt changes during that period. Maintaining the current stable schedule temporarily is often better than stopping suddenly immediately before a stressful professional commitment. Once the event is over and the person remains stable for several days, discontinuation can then be attempted more comfortably. In many patients, the final phase of tapering is the most symptom-sensitive stage even though the dose is tiny. Mild fatigue, body aches, altered sleep, and “not feeling normal” can persist transiently for days to weeks as the GABA system readjusts. These symptoms alone do not necessarily indicate danger. Immediate medical review is important if symptoms such as severe anxiety, panic attacks, marked insomnia, confusion, tremors, perceptual disturbances, palpitations, seizures, or suicidal thoughts occur. Supportive measures that often help during the final taper phase include: regular sleep schedule, hydration, avoiding alcohol, limiting caffeine excess, light exercise/walking, avoiding repeated dose changes.